ConductScience.org, home

Paper23224743

Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.

Geng L and 5 others. J Comput Aided Mol Des, 2012. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases. Papers, record 23224743. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23224743

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.
PubMed
Journal
J Comput Aided Mol Des
PubMed
Year
2012
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Geng LLingling
2Gao JJian
3Cui WWei
4Tang YYancheng
5Ji MMingjuan
6Chen BBozhen

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Matrix MetalloproteinasesMajor topic
ProteinsMajor topic
Amino Acid Sequence
Binding Sites
Catalytic Domain
Computer Simulation
Crystallography, X-Ray
Humans
Models, Molecular
Molecular Sequence Data
Protein Binding
Protein Structure, Secondary
Sequence Homology, Amino Acid
Substrate Specificity

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112051944Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.J Mol Biol2002https://conductscience.org/library/papers/12051944PubMed
210818225The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.FEBS Lett2000https://conductscience.org/library/papers/10818225PubMed
310708863Tissue inhibitors of metalloproteinases: evolution, structure and function.Biochim Biophys Acta2000https://conductscience.org/library/papers/10708863PubMed
48535233Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.Protein Sci1995https://conductscience.org/library/papers/8535233PubMed
59792098Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.Protein Sci1998https://conductscience.org/library/papers/9792098PubMed
69755855TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.FEBS Lett1998https://conductscience.org/library/papers/9755855PubMed
78969305The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain.J Mol Biol1996https://conductscience.org/library/papers/8969305PubMed
812850155Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.J Mol Biol2003https://conductscience.org/library/papers/12850155PubMed
911754341Theory and applications of the generalized Born solvation model in macromolecular simulations.Biopolymers2000https://conductscience.org/library/papers/11754341PubMed
102834383H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.J Biol Chem1988https://conductscience.org/library/papers/2834383PubMed
1118206907Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.J Mol Biol2008https://conductscience.org/library/papers/18206907PubMed
1214531054A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.J Comput Chem2003https://conductscience.org/library/papers/14531054PubMed
139249047
1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile.
Eur J Biochem1997https://conductscience.org/library/papers/9249047PubMed
1421813640Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.J Biol Chem2011https://conductscience.org/library/papers/21813640PubMed
1515048829Exploring protein native states and large-scale conformational changes with a modified generalized born model.Proteins2004https://conductscience.org/library/papers/15048829PubMed
1614648622Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf.J Comput Chem2004https://conductscience.org/library/papers/14648622PubMed
1716200636The Amber biomolecular simulation programs.J Comput Chem2005https://conductscience.org/library/papers/16200636PubMed
188539245Zinc binding in proteins and solution: a simple but accurate nonbonded representation.Proteins1995https://conductscience.org/library/papers/8539245PubMed
1917846036Clustal W and Clustal X version 2.0.Bioinformatics2007https://conductscience.org/library/papers/17846036PubMed
202551898SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.J Biol Chem1989https://conductscience.org/library/papers/2551898PubMed

See all 37 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
32193867Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.J Comput Aided Mol Des2020https://conductscience.org/library/papers/32193867PubMed
29885593Exploring the binding mechanisms of diaminopimelic acid analogs to meso-diaminopimelate dehydrogenase by molecular modeling.J Mol Graph Model2018https://conductscience.org/library/papers/29885593PubMed
27279916HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery.Theranostics2016https://conductscience.org/library/papers/27279916PubMed
26284145Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors.Theranostics2015https://conductscience.org/library/papers/26284145PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP74316PubTator's text mininghttps://conductscience.org/library/genes/4316NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23224743

GET https://conductscience.org/api/papers/v1/23224743/references?page=2